Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia

Br J Haematol. 2015 Jan;168(2):305-8. doi: 10.1111/bjh.13103. Epub 2014 Aug 27.
No abstract available

Keywords: BCR-ABL1; childhood; chronic myeloid leukaemia; imatinib; treatment-free remission.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Benzamides / administration & dosage*
  • Child
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Piperazines / administration & dosage*
  • Pyrimidines / administration & dosage*
  • Remission Induction

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate